Modern Diagnostic & Research Centre IPO GMP Today, Live Rates & Dates
Live Grey Market Premium (GMP) for Modern Diagnostic & Research Centre is ₹ 14. The Kostak rate is - and Subject to Sauda is ₹ 18000+. Check the day-wise GMP trend below.
Check out Modern Diagnostic & Research Centre IPO GMP rates as of today. Modern Diagnostic & Research Centre IPO GMP started in grey market. Stay tuned for the latest IPO GMP numbers of Modern Diagnostic & Research Centre IPO.
Modern Diagnostic & Research Centre IPO GMP made a high of ₹14 on 9th January and made a low of ₹14 on 9th January.
Modern Diagnostic & Research Centre IPO is to open on December 31, 2025. It is a IPO that will raise 40,99,200. The Modern Diagnostic & Research Centre IPO price band is fixed at ₹85 to ₹90 with a market lot of 1600.
Day-wise GMP Trend
| Date | GMP (₹) | Trend | GMP (%) | Kostak | Subject to Sauda |
|---|---|---|---|---|---|
| 09 Jan, 2026 | ₹ 14 | 16% | - | ₹ 18000 | |
| 06 Jan, 2026 | ₹ 14 | 16% | - | - |
Modern Diagnostic & Research Centre IPO Dates
| Event | Date |
|---|---|
| Open Date | 31 Dec, 2025 |
| Close Date | 02 Jan, 2026 |
| Allotment Date | 05 Jan, 2026 |
| Refund Date | 06 Jan, 2026 |
| Credit to Demat | 06 Jan, 2026 |
| Listing Date | 07 Jan, 2026 |
About Modern Diagnostic & Research Centre IPO
Frequently Asked Questions about Modern Diagnostic & Research Centre IPO
What is the GMP of Modern Diagnostic & Research Centre IPO?
The current Grey Market Premium (GMP) of Modern Diagnostic & Research Centre IPO is ₹ 14.
What is the Kostak Price of Modern Diagnostic & Research Centre IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Modern Diagnostic & Research Centre IPO is -.
What is the Subject to Sauda Price of Modern Diagnostic & Research Centre IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is : Retail: ₹ 18000, SHNI: -, BHNI: -.
Quick Links
Disclaimer
Grey Market Premium (GMP) is for information purposes only. It is not an indicator of the listing price. We do not support or encourage trading in the Grey Market. Please consult your financial advisor before making any investment decision.